The latest market report published by Credence Research, Inc. “Deep Brain Stimulation Devices Market – Growth, Future Prospects, Competitive Analysis, 2018 – 2026,” the global deep brain stimulation devices market was valued at US$ 699.6 Mn in 2017 and expected to reach US$ 1,889.4 Mn by 2026, expanding at a CAGR of 11.6% from 2018 to 2026.
Market Insights
Since the first application of deep brain stimulation (DBS) in the 1990s, the indications for the potential use of deep brain stimulation devices have been expanding. At present, over 1.5 million individuals have undergone DBS treatment for several approved and off label indications. Reversibility and titratability are the key features of deep brain stimulation devices augmenting their appeal in the field of clinical neurology. Despite their perceived advantages, the USFDA has been cautious in the approval and widespread adoption of deep brain stimulation treatments. Parkinson’s disease, epilepsy and tremors have been approved by the FDA with dystonia and obsessive compulsive disorders being granted exemption under humanitarian grounds. Conversely, the European commission is being more liberal in granting direct approval for these conditions. DBS has been applied for several conditions with proved benefits. However, due to scarcity of the number of procedures, robust evidence owing to difficulty in performing double blind randomized trials for such conditions is lacking.
Browse the full report Deep Brain Stimulation Devices Market – Growth, Future Prospects, Competitive Analysis, 2018 – 2026 report at https://www.credenceresearch.com/report/deep-brain-stimulation-devices-market
As the global burden of neurological diseases is increasing, the healthcare infrastructure worldwide is augmenting its efforts towards introducing and incorporating new treatment methods and modalities that shall assist in mitigating the ever-growing toll of diseases. High morbidity has therefore created clinical urgency for long-term treatment options such as deep brain stimulation. Deep brain stimulation devices have proven evidence to have an important role in offering potential treatment to conditions such as epilepsy, tremors, and Parkinson’s disease, and are being further explored for their viability in other neurological areas.
Advancements in deep brain stimulation device technologies are shaping the growth of this market. Some of such advancements include customized programming, robot-assisted implantations, integrated pulse generators, and so on. Such progresses have allowed better treatment outcomes and safety profile to deep brain stimulation devices, particularly in treatment of movement disorders. At present, among the several approved applications of deep brain stimulation devices, Parkinson’s disease dominates the global market both in terms of revenue and volume. Parkinson’s disease is a common neurological disease with less treatment alternatives, and the available treatments are often administered for life. Long-term costs of Parkinson’s medications have led to increased adoption of deep brain stimulation devices, therefore gaining a greater market share. Additionally, the recently approved epilepsy application is expected to undergo the fastest growth during the forecast period. Lower therapeutic response to medication and lower outcomes from surgeries will urge chronic patients to adopt deep brain stimulation as a potential treatment.
The global deep brain stimulation devices market is highly competitive and consolidated. The market is characterized by the presence of limited number of players. The major companies operating in this market are engaged in developing next generation devices that shall deliver better treatment outcomes, with expanded application areas with legal sanction. The companies are also actively engaged expanding their geographical reach, and improving distribution channels with partnerships and distribution agreements.
Key Market Movements:
- Growing prevalence of neurodegenerative diseases such as Parkinson’s disease and other movement disorders
- Lack of availability of viable and more efficacious treatment options for such diseases
- Growing preference of neurostimulation devices for treatment of neurological conditions
- Intensive marketing strategies in North America and Europe
- Intensive research and development activities promoting the efficacy of DBS devices
ToC:
Chapter 1. Preface
1.1. Report Description
1.1.1. Study Purpose
1.1.2. Target Audience
1.1.3. USP and Key Offerings
1.2. Market Segmentation
1.3. Research Scope
1.4. Research Methodology
1.4.1. Phase I – Secondary Research
1.4.2. Phase II – Primary Research
1.4.3. Phase III – Expert Panel Review
1.4.4. Assumptions
1.5. Market Segmentation
Chapter 2. Executive Summary
2.1. Global Deep Brain Stimulation Devices Market Portraiture
2.2. Global Deep Brain Stimulation Devices Market, by Modality, 2017 (US$ Mn)
2.3. Global Deep Brain Stimulation Devices Market, by Application, 2017 (US$ Mn)
2.4. Global Deep Brain Stimulation Devices Market, by Geography, 2017 (US$ Mn)
Chapter 3. Global Deep Brain Stimulation Devices Market: Dynamics and Future Outlook
3.1. Overview
3.2. Drivers
3.3. Challenges
3.4. Opportunities
3.5. Attractive Investment Proposition, by Geography, 2017
3.6. Competitive Analysis: Global Deep Brain Stimulation Devices Market, by Key Players, 2017
Chapter 4. Global Deep Brain Stimulation Devices Market, by Modality, 2016-2026 (US$ Mn)
4.1. Overview
4.2. Subthalamic Nucleus (STN) DBS
4.3. Globus Pallidus Interna (GPi) DBS
4.4. Thalamus (Vim) DBS
Chapter 5. Global Deep Brain Stimulation Devices Market, by Application, 2016-2026 (US$ Mn)
5.1. Overview
5.2. Parkinson’s Disease
5.3. Epilepsy
5.4. Obsessive Compulsive Disorder (OCD)
5.5. Dystonia
5.6. Essential Tremors
…………..toc continued
Browse the full report Deep Brain Stimulation Devices Market – Growth, Future Prospects, Competitive Analysis, 2018 – 2026 report at https://www.credenceresearch.com/report/deep-brain-stimulation-devices-market
About Us:
Credence Research is a worldwide market research and counseling firm that serves driving organizations, governments, non legislative associations, and not-for-benefits. We offer our customers some assistance with making enduring enhancements to their execution and understand their most imperative objectives. Over almost a century, we’ve manufactured a firm extraordinarily prepared to this task.
Who we are
Credence Research is a worldwide firm, containing more than 15 research consultants and almost 100 research and information professionals.Our customers mirror our worldwide nature. Around 45% are in Europe, 30% in the Americas, 13% in Asia Pacific and 12% in the Middle East and Africa. Our firm is intended to work as one. We are a solitary global research organization united by a solid arrangement of qualities, concentrated on customer effect.
“In DBS surgery, electrodes are inserted into a targeted area of the brain, using MRI (magnetic resonance imaging) and recordings of brain cell activity during the procedure. A second procedure is performed to implant an IPG, impulse generator battery (like a pacemaker). The IPG is placed under the collarbone or in the abdomen. The IPG provides an electrical impulse to a part of the brain involved in motor function. Those who undergo DBS surgery are given a controller to turn the device on or off.
DBS is certainly the most important therapeutic advancement since the development of levodopa. It is most effective for people who experience disabling tremors, wearing-off spells and medication-induced dyskinesias, with studies showing benefits lasting at least five years. That said, it is not a cure and it does not slow PD progression. It is also not right for every person with PD. It is not thought to improve speech or swallow issues, thinking problems or gait freezing.”
Media Contact
Company Name: Credence Research, Inc
Contact Person: Chris Smith, Global Sales Manager
Email: Send Email
Phone: +1-800-361-8290
Address:105 N 1st ST #429, SAN JOSE, CA 95103 US
City: SAN JOSE
State: California
Country: United States
Website: https://www.credenceresearch.com/report/deep-brain-stimulation-devices-market